BONALDO, GIULIA
BONALDO, GIULIA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.019 secondi).
Adverse event reporting with immune checkpoint inhibitors in older patients: Age subgroup disproportionality analysis in vigibase
2021-01-01 Noseda R.; Bonaldo G.; Motola D.; Stathis A.; Ceschi A.
Antibacterial prescription in Italian preschool children: analysis of 7 years of data from the Emilia-Romagna region reimbursement database
2019-01-01 D'Annibali O.; Bonaldo G.; Donati M.; Smabrekke L.; Motola D.; Vaccheri A.
Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions
2019-01-01 Bonaldo G.; Andriani L.A.; D'Annibali O.; Motola D.; Vaccheri A.
Comparative risk/benefit profile of biosimilar and originator erythropoiesis-stimulating agents (ESAs): data from an Italian observational study in nephrology
2018-01-01 Motola, Domenico*; Vaccheri, Alberto; Roncadori, Andrea; Donati, Monia; Bonaldo, Giulia; Covezzoli, Anna; Polidori, Piera; Bianchi, Stefano
Direct-acting oral anticoagulants and alopecia: The valuable support of postmarketing data
2020-01-01 Bonaldo G.; Vaccheri A.; Motola D.
Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization’s database
2020-01-01 Bonaldo G.; Vaccheri A.; Melis M.; Motola D.
Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data
2020-01-01 Bonaldo G.; Noseda R.; Ceschi A.; Vaccheri A.; Motola D.
Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System
2021-01-01 Bonaldo G.; Montanaro N.; Vaccheri A.; Motola D.
Non-commercial trials on medicines submitted to the Ethics Committee of the University Hospital of Bologna (Italy) along 8 years of activity: time to update rules and recommendations
2019-01-01 Montanaro N.; Bonaldo G.; Proni S.; Chiabrando G.; Motola D.
The prescription of antimicrobials by general practitioners: the differences between north and south Italian provinces
2020-01-01 Bonaldo G.; Bianchi S.; Ancona D.; Procacci C.; Natalini N.; Motola D.; Vaccheri A.
Removal of the EMA orphan designation upon request of the sponsor: cui prodest?
2021-01-01 Montanaro N.; Bonaldo G.; Motola D.
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
2021-01-01 Bonaldo G.; Montanaro N.; AlbertoVaccheri; Motola D.
Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
2019-01-01 Bonaldo G.; Vaccheri A.; D'Annibali O.; Motola D.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Adverse event reporting with immune checkpoint inhibitors in older patients: Age subgroup disproportionality analysis in vigibase | Noseda R.; Bonaldo G.; Motola D.; Stathis A.; Ceschi A. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | Nr_64_Cancers Check point inhibitors.pdf; cancers-13-01131-s001.pdf |
| Antibacterial prescription in Italian preschool children: analysis of 7 years of data from the Emilia-Romagna region reimbursement database | D'Annibali O.; Bonaldo G.; Donati M.; Smabrekke L.; Motola D.; Vaccheri A. | 2019-01-01 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | - | 1.01 Articolo in rivista | - |
| Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions | Bonaldo G.; Andriani L.A.; D'Annibali O.; Motola D.; Vaccheri A. | 2019-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 1.01 Articolo in rivista | - |
| Comparative risk/benefit profile of biosimilar and originator erythropoiesis-stimulating agents (ESAs): data from an Italian observational study in nephrology | Motola, Domenico*; Vaccheri, Alberto; Roncadori, Andrea; Donati, Monia; Bonaldo, Giulia; Covezzoli, Anna; Polidori, Piera; Bianchi, Stefano | 2018-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Direct-acting oral anticoagulants and alopecia: The valuable support of postmarketing data | Bonaldo G.; Vaccheri A.; Motola D. | 2020-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization’s database | Bonaldo G.; Vaccheri A.; Melis M.; Motola D. | 2020-01-01 | JOURNAL OF THROMBOSIS AND THROMBOLYSIS | - | 1.01 Articolo in rivista | Manuscript CID.pdf |
| Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data | Bonaldo G.; Noseda R.; Ceschi A.; Vaccheri A.; Motola D. | 2020-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | Nr_59_SR_Rotairus vaccine safety.pdf |
| Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System | Bonaldo G.; Montanaro N.; Vaccheri A.; Motola D. | 2021-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Non-commercial trials on medicines submitted to the Ethics Committee of the University Hospital of Bologna (Italy) along 8 years of activity: time to update rules and recommendations | Montanaro N.; Bonaldo G.; Proni S.; Chiabrando G.; Motola D. | 2019-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| The prescription of antimicrobials by general practitioners: the differences between north and south Italian provinces | Bonaldo G.; Bianchi S.; Ancona D.; Procacci C.; Natalini N.; Motola D.; Vaccheri A. | 2020-01-01 | EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | - | 1.01 Articolo in rivista | - |
| Removal of the EMA orphan designation upon request of the sponsor: cui prodest? | Montanaro N.; Bonaldo G.; Motola D. | 2021-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice | Bonaldo G.; Montanaro N.; AlbertoVaccheri; Motola D. | 2021-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017 | Bonaldo G.; Vaccheri A.; D'Annibali O.; Motola D. | 2019-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |